AUTHOR=Dahal Ram Hari , Kim Shukho , Kim Yu Kyung , Kim Eun Soo , Kim Jungmin 

TITLE=Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis

JOURNAL=Frontiers in Microbiology

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1174832

DOI=10.3389/fmicb.2023.1174832

ISSN=1664-302X

ABSTRACT=<p>The collection of whole microbial communities (bacteria, archaea, fungi, and viruses) together constitutes the gut microbiome. Diet, age, stress, host genetics, and diseases cause increases or decreases in the relative abundance and diversity of bacterial species (dysbiosis). We aimed to investigate the gut microbial composition at different taxonomic levels of healthy controls (HCs) with active Crohn’s disease (CD), ulcerative colitis (UC), and ischemic colitis (IC) using culture- and non-culture-based approaches and identify biomarkers to discriminate CD, UC, or IC. We determined the specific changes in the gut microbial profile using culture-independent (16S rRNA gene amplicon sequencing) as well as culture-based (culturomic) approaches. Biomarkers were validated using quantitative Real-Time PCR (qPCR). In both methods, bacterial diversity and species richness decreased in disease-associated conditions compared with that in HCs. Highly reduced abundance of <italic>Faecalibacterium prausnitzii</italic> and <italic>Prevotella</italic> sp. and an increased abundance of potentially pathogenic bacteria such as <italic>Enterococcus faecium</italic>, <italic>Enterococcus faecalis</italic>, and <italic>Escherichia coli</italic> in all CD, UC, or IC conditions were observed. We noted a high abundance of <italic>Latilactobacillus sakei</italic> in CD patients; <italic>Ligilactobacillus ruminis</italic> in UC patients; and <italic>Enterococcus faecium</italic>, <italic>Escherichia coli</italic>, and <italic>Enterococcus faecalis</italic> in IC patients. Highly reduced abundance of <italic>Faecalibacterium prausnitzii</italic> in all cases, and increased abundance of <italic>Latilactobacillus sakei</italic> and <italic>Enterococcus faecium</italic> in CD, <italic>Ligilactobacillus ruminis</italic> and <italic>Enterococcus faecium</italic> in UC, and <italic>Enterococcus faecium</italic>, <italic>Escherichia coli</italic>, and <italic>Enterococcus faecalis</italic> in IC could be biomarkers for CD, UC, and IC, respectively. These biomarkers may help in IBD (CD or UC) and IC diagnosis.</p>